Cargando…
Aberrant expression of microRNA-99a and its target gene mTOR associated with malignant progression and poor prognosis in patients with osteosarcoma
BACKGROUND: The mammalian target of rapamycin (mTOR) has been reported to act as a target gene of microRNA (miR)-99a in various cancer cells and identified as an independent prognostic marker of human osteosarcoma. The aim of this study was to investigate the clinical significance of miR-99a/mTOR ax...
Autores principales: | Zhao, Jiali, Chen, Fengli, Zhou, Quan, Pan, Wei, Wang, Xinhong, Xu, Jin, Ni, Li, Yang, Huilin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4806763/ https://www.ncbi.nlm.nih.gov/pubmed/27073323 http://dx.doi.org/10.2147/OTT.S102421 |
Ejemplares similares
-
MicroRNA-99 Family Targets AKT/mTOR Signaling Pathway in Dermal Wound Healing
por: Jin, Yi, et al.
Publicado: (2013) -
microRNA-99a Restricts Replication of Hepatitis C Virus by Targeting mTOR and De Novo Lipogenesis
por: Lee, Eun Byul, et al.
Publicado: (2020) -
mTOR: An attractive therapeutic target for osteosarcoma?
por: Ding, Liu, et al.
Publicado: (2016) -
Downregulation of microRNA-605 indicates poor prognosis and promotes the progression of osteosarcoma
por: Yi, Xiuling, et al.
Publicado: (2020) -
Downregulation of CD99 and upregulation of human leukocyte antigen class II promote tumor aggravation and poor survival in patients with osteosarcomas
por: Zhou, Quan, et al.
Publicado: (2014)